Polyendorcine Metabolic Ovarian Syndrome (PMOS)PCOS & HealthCare
– A Functional Medicine Approach to Healing from the Root
Understanding Polyendorcine Metabolic Ovarian Syndrome (PMSO) PCOS
PCOS is now being recognised by a new name: polyendocrine metabolic ovarian syndrome (PMOS). The change follows 11 years of international research and 'intentionally' reflects a better understanding of the condition.
PMOS affects nearly 170 million women worldwide and is about much more than the ovaries. In fact, many women diagnosed with the condition do not have ovarian cysts at all, but instead experience a cluster of symptoms affecting many areas of health
Experts now understand that it is a complex endocrine (hormonal) and metabolic condition that can affect many systems throughout the body, with ovarian symptoms being just one part of it.
PMOS develops over time and affects each woman differently, with the underlying cause varying from woman to woman, which is why a one-size-fits-all approach often falls short and many women are dismissed or struggle for years before receiving a diagnosis.
PMOS is emerging as a more accurate term for PCOS and every word in the name is intentional.
POLYENDOCRINE highlights the involvement of multiple hormonal systems, including insulin, androgens, and neuroendocrine hormones such as LH and FSH. This reflects that the condition extends far beyond the ovaries alone.
METABOLIC recognises the strong connection between PMOS and metabolic health, including insulin resistance, increased risk of type 2 diabetes, weight challenges, and cardiovascular disease.
OVARIAN refers to ovulatory dysfunction, where irregular or absent periods occur due to disrupted ovulation.
PMSO is a complex endocrine and metabolic condition that affects many aspects of a woman’s health. It is typically characterised by a cluster of symptoms that may occur individually or together, including:
1. Hormonal balance, menstrual cycles, and fertility
2. Endocrine and metabolic function, Increased sensitivity to stress
3. Heart and cardiovascular health
4. Skin and hair concerns, including acne, excess hair growth, and hair thinning
5. Emotional wellbeing, including anxiety, depression, and other mental health challenges
Having a clear understanding of appropriate testing and treatment options is essential, empowering you to make informed decisions and advocate for your health needs.
PMSO is not caused by a single factor.
Rather, it often develops through a combination of genetic, metabolic, environmental, and lifestyle influences.
Factors that may increase the likelihood of developing PMSO include:
Nutritional deficiencies or dietary patterns that affect metabolic health
Exposure to environmental pollutants and hormone-disrupting chemicals
Chronic stress and impaired stress response (HPA axis dysregulation)
Insufficient or poor-quality sleep
Gut microbiome imbalances and increased intestinal permeability (“leaky gut”)
Infections or chronic inflammatory processes
Thyroid dysfunction
Impaired detoxification pathways
Mycotoxin exposure (mould)
Genetic predisposition
Obesity or metabolic dysfunction
These influences can contribute to a cascade of physiological changes, including hyperinsulinaemia, oxidative stress, chronic low-grade inflammation, elevated androgens, disrupted ovarian follicle development, and irregular menstrual cycles.
Your Body Is Communicating
“You are not alone, and there is hope. Your body is never working against you.”
PMOS can often feel like an emotional rollercoaster. Hormonal changes, uncertainty, and the physical symptoms themselves can create significant stress, which may further amplify the cycle.
From a functional medicine perspective, symptoms are not viewed as random or inconvenient problems to suppress. Instead, they are signals - your body’s way of communicating that something within the system needs attention.
When we begin to listen to those signals, we can start addressing the deeper imbalances that may be driving them.
PMOS: Every Woman Is Unique
PMOS does not look the same for everyone, which is why many women are dismissed or struggle for years before receiving a diagnosis. Research increasingly recognises several phenotypes, or patterns, that reflect different underlying mechanisms.
These may overlap and evolve over time, which is why personalised assessment and treatment are essential.
Understanding which patterns may be contributing to your symptoms allows health care to be more targeted and effective.
Why PMOS Often Goes Unrecognised:
• A normal ultrasound does not rule it out - many women with PMOS do not have ovarian cysts
• Blood sugar may appear “normal” while underlying insulin issues remain undetected because fasting insulin was never checked
• PMOS can occur in lean women too, but this form is commonly overlooked
• Not everyone develops noticeable facial hair or excess hair growth, even when androgen levels are elevated
• Cycles may seem regular while ovulation is still inconsistent or absent
• Starting birth control at a young age can sometimes hide symptoms and delay recognition of the underlying metabolic condition
Alongside assessing symptoms and medical history, we use comprehensive testing to help guide personalised health care.
A Functional Medicine Approach: Addressing the Root Cause
PMOS develops over time and affects each woman differently, which is why a one-size-fits-all approach often falls short.
At LITHE Health Clinic, we take a personalised, root-cause approach that looks beyond symptom management. By understanding your health history, lifestyle, environment, and lived experiences, we aim to uncover the factors contributing to your symptoms and restore balance across the body’s systems.
As part of this process, we carefully review your test results and medical records alongside your history, symptoms, and questionnaires to create a safe, evidence-based, and individualised care plan. We also offer comprehensive advanced testing to support deeper insight into your health.
Rather than simply masking symptoms, we focus on supporting long-term healing and treating the underlying imbalances driving them. This approach has always been essential in the clinical management of PCOS.
At LITHE Health Clinic, this process may include:
Comprehensive health assessments
Advanced functional laboratory testing
In-depth interpretation of results
Nutritional therapy
Targeted supplement and nutraceutical protocols
Lifestyle and nervous system support
A supportive therapeutic partnership throughout your journey
Available in person or online worldwide, in both Polish and English. We offer 30 min free discovery call.
Ref.
1. Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020;13(4):261‑271. doi: 10.4103/jhrs.JHRS_95_18
2. Rao M, Broughton SK, LeMieux MJ. Cross-sectional study on the knowledge and prevalence of PCOS at a multiethnic university. Prev Med. 2020; e0028. doi: 10.1097/pp9.0000000000000028
3. Riestenberg C, Jagasia A, Markovic D, Buyalos RP, Azziz R. Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences. J Clin Endocrinol Metab. 2022;107(2):575‑585. doi: 10.1210/clinem/dgab613
4. Hoyos LR, Putra M, Armstrong AA, et al. Measures of patient dissatisfaction with health care in polycystic ovary syndrome: retrospective analysis. J Med Internet Res. 2020;22(4):e16541. doi: 10.2196/16541
5. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab.2023;108(10):2447‑2469. doi: 10.1210/clinem/dgad463
6. Sendur SN, Yildiz BO. Influence of ethnicity on different aspects of polycystic ovary syndrome: a systematic review. Reprod Biomed Online. 2021;42(4):799‑818. doi: 10.1016/j.rbmo.2020.12.006
7. Elghobashy M, Lau GM, Davitadze M, et al. Concerns and expectations in women with polycystic ovary syndrome vary across age and ethnicity: findings from PCOS Pearls Study. Front Endocrinol (Lausanne). 2023;14:1175548. doi: 10.3389/fendo.2023.1175548
8. Khatlani K, Njike V, Costales VC. Effect of lifestyle intervention on cardiometabolic risk factors in overweight and obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord.2019;17(10):473‑485. doi: 10.1089/met.2019.0049
9. Abdolahian S, Tehrani FR, Amiri M, et al. Effect of lifestyle modifications on anthropometric, clinical, and biochemical parameters in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20(1):71. doi: 10.1186/s12902-020-00552-1
10. Aboeldalyl S, James C, Seyam E, Ibrahim EM, Shawki HE-D, Amer S. The role of chronic inflammation in polycystic ovarian syndrome-a systematic review and meta-analysis. Int J Mol Sci. 2021;22(5):2734. doi: 10.3390/ijms22052734
11. Abraham Gnanadass S, Divakar Prabhu Y, Valsala Gopalakrishnan A. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet. 2021;303(3):631‑643. doi: 10.1007/s00404-020-05951-2
12. Kim KW. Unravelling polycystic ovary syndrome and its comorbidities. J Obes Metab Syndr. 2021;30(3):209‑221. doi: 10.7570/jomes21043
13. Wekker V, van Dammen L, Koning A, et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020;26(6):942‑960. doi: 10.1093/humupd/dmaa029
14. Wang Y, Ni Z, Li K. The prevalence of anxiety and depression of different severity in women with polycystic ovary syndrome: a meta-analysis. Gynecol Endocrinol. 2021;37(12):1072‑1078. doi: 10.1080/09513590.2021.1942452
15. Fu L, Xie N, Qu F, Zhou J, Wang F. The association between polycystic ovary syndrome and metabolic syndrome in adolescents: a systematic review and meta-analysis. Reprod Sci. 2023;30(1):28‑40. doi: 10.1007/s43032-022-00864-8
16. Singh S, Pal N, Shubham S, et al. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med. 2023;12(4):1454. doi: 10.3390/jcm12041454
17. Kawa IA, Masood A, Fatima Q, et al. Endocrine disrupting chemical bisphenol A and its potential effects on female health. Diabetes Metab Syndr. 2021;15(3):803‑811. doi: 10.1016/j.dsx.2021.03.031
18. Zou Y, Liao R, Cheng R, Chung H, Zhu H, Huang Y. Alterations of gut microbiota biodiversity and relative abundance in women with PCOS: a systematic review and meta-analysis. Microb Pathog. 2023;184:106370. doi: 10.1016/j.micpath.2023.106370
19. Gu Y, Zhou G, Zhou F, et al. Gut and vaginal microbiomes in PCOS: implications for women's health. Front Endocrinol (Lausanne). 2022;13:808508. doi: 10.3389/fendo.2022.808508
20. Moslehi N, Zeraattalab-Motlagh S, Rahimi Sakak F, Shab-Bidar S, Tehrani FR, Mirmiran P. Effects of nutrition on metabolic and endocrine outcomes in women with polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials. Nutr Rev. 2023;81(5):555‑577. doi: 10.1093/nutrit/nuac075
21. Di Lorenzo M, Cacciapuoti N, Lonardo MS, et al. Pathophysiology and nutritional approaches in polycystic ovary syndrome (PCOS): a comprehensive review. Curr Nutr Rep. 2023;12(3):527‑544. doi: 10.1007/s13668-023-00479-8
22. Menichini D, Ughetti C, Monari F, Di Vinci PL, Neri I, Facchinetti F. Nutraceuticals and polycystic ovary syndrome: a systematic review of the literature. Gynecol Endocrinol. 2022;38(8):623‑631. doi: 10.1080/09513590.2022.2089106
23. Hafizi Moori M, Nosratabadi S, Yazdi N, Kasraei R, Abbasi Senjedary Z, Hatami R. The effect of exercise on inflammatory markers in PCOS women: a systematic review and meta-analysis of randomized trials. Int J Clin Pract. 2023;2023:3924018. doi: 10.1155/2023/3924018
24. Dema H, Videtič Paska A, Kouter K, et al. Effects of mindfulness-based therapy on clinical symptoms and DNA methylation in patients with polycystic ovary syndrome and high metabolic risk. Curr Issues Mol Biol.2023;45(4):2717‑2737. doi: 10.3390/cimb45040178
25. Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019;3(3):CD007506. doi: 10.1002/14651858.CD007506.pub4
26. Patten RK, Pascoe MC, Moreno-Asso A, Boyle RA, Stepto NK, Parker AG. Effectiveness of exercise interventions on mental health and health-related quality of life in women with polycystic ovary syndrome: a systematic review. BMC Public Health. 2020;21(1):2310. doi: 10.1186/s12889-021-12280-9
27. Hu J, Shi W, Xu J, et al. Complementary and alternative medicine for the treatment of abnormal endometrial conditions in women with PCOS: a systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2021;2021:5536849. doi: 10.1155/2021/5536849
28. Zheng R, Qing P, Han M, et al. The effect of acupuncture on glucose metabolism and lipid profiles in patients with PCOS: a systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2021;2021:5555028. doi: 10.1155/2021/5555028